Invitae offers gene panels and single-gene testing for a broad range of clinical areas including hereditary cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, and hematology.
The price is on a strong weekly pattern, decent long opportunity on probable bullish rebound.
Nice long ~2 year consolidation is in progress, recent reject from the top side of wedge will present entry opportunities
Entry target ~ 1.15-1.35 (1.25 average)
Interesting medical treatments currently in trials
Long term play
Miromatrix Medical Inc. engages in the development of biological human organs to solve the chronic shortage of transplantable organs.
114,000 people in the U.S. are waiting for a life-saving organ transplant, and more than half will die due to a lack of available organs.
Miromatrix Medical trial is expected to begin in the second half of 2022 and will assess the...
In a recent days I was looking into CTI's price movement. It's very interesting, if you look at candlestick performance, candlestick patterns e t.c. And today I'm looking on a big zone of interest for trading. As you can see, spike in volume like this means it's going to go up very shortly. My recommendation would be to buy at the lowest in this zone, which you...
As one of my hobbies is thinking about different spheres of possible crypto-influence, i am always looking into something new. For example, medicine in which data science has taken it's toll. One of project like this, which I found on twitter, was ClinTex. One of strategies for investing is to diverse your funds and think about net-profit which it wil give you in...
The company Ontrak has always proved to be an excellent partner for care centers, unfortunately in recent months one of their major customers has decided to abandon the contract with the company Ontrak.
This has led to a rapid decline in prices, but the company is proving to have a good basis to start again, the technology they produce is essentially unique and...
ENTRY: 40.85 EUR
TARGET: 50.00 EUR (+22%)
STOP: 37.00 EUR
1.) Fresenius is breaking out of the POC box (Point of Control/Point of Interest). Technicall, an upward movement is expected.
2.) 42.80 EUR level needs to fall, so that an attack on the mid-term resistance (44.00 EUR) can occure.
3.) Fresenius works intensively at the cost reduction, which should...
Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves.
You can also see:
There is still rooms for the Williams 224 to climb further.
The historical volatility is lower than it was in...
Hi. In this 1D chart I've plotted the Elliott Wave patterns from the latest months and from it concluded that the next wave will be an impulse wave, as a clear correction wave has just finished.
The size of the incoming impulse is of course subject to speculation, but the certainty of it is substantial according to my analys of the latest patterns.
The flat volume should be increasing any day, for better or worse. I'm thinking for better. It has built strong support on the 100 day, & RSI is trending up while price is riding an upward trend line. It looks decent, and now is a good time for a lot of stocks to break out of their slumps.
I'm noticing numerous stocks at a tipping point so I think Monday or...